company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32174000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32174000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,703000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5516000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2536000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28491000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28491000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-740000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,100000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-640000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-640000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29131000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29131000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q1,2013-01-01,2013-03-31,2014-06-24 17:16:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38952000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38952000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,699000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6207000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7701000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24345000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24345000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-691000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-691000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-691000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,25036000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,25036000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41078000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41078000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,557000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5614000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1972000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32935000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32935000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-237000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-237000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-237000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,33172000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,33172000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44080000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44080000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,694000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5166000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3032000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35188000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35188000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1066000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1066000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1066000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,36254000.0
Theravance Biopharma Inc,TBPH,,0001583107,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,36254000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60018000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60018000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,732000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13545000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,942000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44799000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44799000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1620000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1620000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1620000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,46419000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,46419000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,46419000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q1,2014-01-01,2014-03-31,2015-05-13 17:03:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-58215000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58215000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,686000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5919000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,170000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-51440000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-51440000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-261000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9981000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5783000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4459000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4459000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,277541000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,46557000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,324098000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,324098000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,268199000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54495000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54495000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1075000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8957000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8086000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36377000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36377000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-461000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-135888000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26493000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-109856000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-109856000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,-131000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,393000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,262000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,262000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-145971000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-42539000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-42539000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-765000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-23024000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,140000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34166000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-833000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9684000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9684000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,131000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-289000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-158000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-158000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-33013000.0
Theravance Biopharma Inc,TBPH,,0001583107,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4550000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42474000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42474000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,825000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2506000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12359000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-56514000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-56514000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-657000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10659000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,53470000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,42154000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,42154000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,25753000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,291000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26044000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26044000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11684000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:02:41+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,765000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47604000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47604000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,747000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8987000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8744000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-46614000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-46614000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-710000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-400000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,42409000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,41299000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,41299000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1557000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-51000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1506000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1506000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3809000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6508000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47315000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47315000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,720000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10131000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4481000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31983000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31983000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-674000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62763000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,62089000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,62089000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-48000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-34000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-82000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-82000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30024000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3119000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44826000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44826000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,697000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1923000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12231000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33746000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33746000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-606000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61952000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28055000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-34503000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-34503000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-24138000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,77980000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,53842000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,53842000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14407000.0
Theravance Biopharma Inc,TBPH,,0001583107,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2997000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42150000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42150000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,699000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9036000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6106000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26309000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26309000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-684000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17069000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16385000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16385000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27802000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1782000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26020000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26020000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16096000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 22:00:03+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9494000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47225000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47225000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,454000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12469000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2167000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32135000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32135000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-638000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-91382000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23445000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-68575000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-68575000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,119366000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,904000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,120270000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,120270000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19560000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-18982000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33961000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33961000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,791000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22262000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1524000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12432000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12432000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-413000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-77177000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27750000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49840000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49840000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,464000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,481000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,481000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-61791000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-67333000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-67333000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1175000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24022000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14023000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28113000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28113000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-400000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-69008000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23203000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-46205000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-46205000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,222498000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,109015000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,942000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,332455000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,332455000.0
Theravance Biopharma Inc,TBPH,,0001583107,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,258137000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65319000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65319000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1083000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11759000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2451000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-50026000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-50026000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-587000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-159217000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,36282000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-123522000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-123522000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1216000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1216000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1216000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 06:22:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-174764000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66287000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66287000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,976000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5530000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,15036000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44745000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44525000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-738000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-72774000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,84688000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11176000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11176000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2657000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,373000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3030000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3030000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30319000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3717000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-2985000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66877000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66877000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,950000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20232000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16384000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-62079000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-62299000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-826000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-53830000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,69419000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14763000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14763000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-789000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-789000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-789000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-48325000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7912000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-86922000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-86922000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42720000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44202000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44202000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-255000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2970000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44475000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,41250000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,41250000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1323000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-692000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,631000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,631000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2321000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3737000.0
Theravance Biopharma Inc,TBPH,,0001583107,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65087000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65087000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1007000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17372000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,96640000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,49932000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,49825000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2771000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54839000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,17000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,46299000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11294000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11294000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1680000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1680000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1680000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36851000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 06:11:30+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4473000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40818000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40818000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1119000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9385000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-31330000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-61644000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-61537000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1094000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47073000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,90129000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,41962000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,41962000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2742000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5144000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2402000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2402000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21977000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3738000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-8928000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59433000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59433000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1069000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10036000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-649000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-48977000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-48977000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1875000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-64500000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,113022000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,46647000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,46647000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-322000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-322000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-322000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2652000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-572000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50186000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50186000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1286000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-990000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2288000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-52178000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-52178000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1500000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16849000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,20000000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97742000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,99393000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,99393000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,229441000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1431000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1268000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,229604000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,229604000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,276819000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3737000.0
Theravance Biopharma Inc,TBPH,,0001583107,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-2289000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72580000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72580000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1316000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,986000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7607000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18522000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-81193000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-81193000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1220000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-148138000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,77198000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-72160000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-72160000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1433000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1433000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1433000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 16:32:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-154786000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39838000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39838000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1551000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1030000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7377000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18150000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-48030000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-48030000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-576000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59890000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5000000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54170000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1296000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1296000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2605000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1797000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4402000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4402000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-44924000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,11753000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,21000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-58431000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58431000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-7543000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-5045000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-45889000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,72286000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-44622000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-44622000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-77000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-158384000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,134800000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23656000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23656000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-134000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-134000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-134000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-68412000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5344000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-65606000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-65606000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11117000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6253000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,52955000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-69071000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-64352000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-64352000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1303000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57486000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,72850000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14061000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14061000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2152000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,869000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-261000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1544000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1544000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-51835000.0
Theravance Biopharma Inc,TBPH,,0001583107,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,9081000.0
